I find it odd that spewage is not on the list. I'm starting to wonder about that moniker and it's role here.
Here's something else I read earlier today. blackmarango was caught red handed using another alias,.......
"BETTER4NOW".....Check it out
He was bragging about all the dividends he was making here. He bought a boatload at $30 share. Maybe he should change his name to mainecoastloser1.
I have that email, I'm looking for their personal addresses.
Last year he was over the GERN board telling everyone how smart an investor he was. I wonder how many poor souls he suckered with his free investment advice.
Like it or not, the BOD and Scarlett will do everything in their power to get the share price into the stratosphere. My reasoning? What would you do? Vote for more dilution so they become worthless? I don't think so!
nyjets1212 • Apr 19, 2016 2:56 PM
K 1 Tax Form from Linn ???
What's this about? Is it legal or a scam? I lost $2,000 last year with Linn after heavy trading with the stock & now my tax person is saying on paper (K1 Tax form), I made $160,000 with Linn & must pay $ 39,000 in taxes!
Sentiment: Strong Sell
Sort: Newest | Oldest | Most Replied
Expand all replies
tooflessinseattle • 19 hours ago
nyjets1212, I had the exact same thing happen. Being a Master Limited Partnership, those who invested in the company are liable for the taxes on any profit they made. Somehow these weasels figured out a way to record a profit in 2015 before filing for bankruptcy in 2016. I had to pay taxes on $43,000.00 (line 13 on the K1 Form. I paid 11K in taxes. After that, I sold every MLP that I own in my portfolio as the liabilities from any profits is paid by the shareholders. The president of Linn is the biggest liar EVER. I have heard there are many lawsuits filed against the brokerage firms that recommended this POS company to their clients. If you only lost 2K on the stock, you got out in the nick of time. Less
Accused Scarlet of trying to keep the share price depressed so he could load up on options at very low price. Anyone else hear that? Scarlet promptly cut him off.
8.2.1 Clinical Development Milestones. For clarity, the provisions of only one of the milestone clauses (a) or (b) of this Section 8.2.1 will apply for any Phase 3 clinical study of a Licensed Product under the Global Development Plan, depending on whether or not Geron has exercised its US Opt-In Rights pursuant to Section 2.2.2 as further provided below. In the event that a combined Phase 2/3 clinical study is conducted in respect of a Licensed Product (irrespective of whether that study is initially established as a combined study or transitions into a combined study once it is under way), where the Phase 2 part of that study satisfies the definition of a “Phase 2” clinical study and the Phase 3 part of that trial satisfies the definition of a “Phase 3” clinical study hereunder, the milestone payment set forth in Section 8.2.1(a) or (b), as applicable, shall be payable upon the first dosing of a Licensed Product in the [*] human subject in the Phase 3 part of such clinical study.
"In return Janssen and Pharmacyclics will split profits equally and share development and commercialisation costs."
Geron will receive 20% MOL, of the NET. In the Pharmacyclics agreement, if there is no profit, then they $0.00. In the Geron agreement we will get 20% no matter what the profit is.